Navigation Links
Pursuit's Peter Robinson Publishes "Grading Pharma's Use of New Commercial Sales Models"
Date:8/21/2014

Chester, NJ (PRWEB) August 21, 2014

Pursuit Solutions (http://www.pursuit-solutions.com), a provider of personal selling optimization technology and services for Life Sciences sales and marketing organizations, announced the publication of “Grading Pharma’s Use of New Commercial Sales Models” by Peter Robinson, co-founder and head of Measurement & Analytics.

The article examines some innovative models used to improve sales and marketing yield that are being tested in the pharmaceutical market. Robinson grades the industry on its progress against each model and proposes solutions to close remaining gaps.

To view the full article, visit http://www.pm360online.com/grading-pharmas-use-of-new-commercial-sales-models/.

About Pursuit Solutions

Pursuit Solutions provides sales and marketing optimization solutions for Life Sciences. Its flagship product, ClearSky, provides the pharmaceutical Field Force with an intuitive and powerful Closed-Loop Marketing (CLM) and Sales Force Automation (SFA) solution, that in concert with the client’s Multi-Channel Marketing (MCM) system enables the user to be aware of marketing touch-points, receive data-driven Interactive Visual Aid (IVA) and other tactic recommendations, and cater presentations to their customers’ interests. ClearView, the company’s business intelligence platform, is designed specifically for the pharmaceutical industry, combining Field Force, Marketing and Managed Markets metrics and insights in one place.

Pursuit's Data Management, Campaign Operations, and Strategy & Analytics capabilities enable its clients to take advantage of alignment across sales and marketing channels, so that customers have a valuable and consistent experience.

Pursuit Solutions is headquartered in Chester, NJ, with offices in Boston, MA, and in the southern San Francisco and Orange County, CA areas. For more information, visit http://www.pursuit-solutions.com.

Read the full story at http://www.prweb.com/releases/2014/08/prweb12108877.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. Pursuit's Elissa Guerra and Eunjoo Pluenneke to Present on Mobile Strategy at Digital Pharma West Conference
2. Elsevier / MEDai Names Dr. Peter Edelstein as Chief Medical Officer and Dr. Gerald Osband as Director of Product Strategy
3. Dr. Peter C. Neligan, Author of 3rd Edition of Elseviers Plastic Surgery Text, Available for Comment on the Contributions of Dr. Joseph Murray
4. PDL BioPharma Appoints Peter Garcia as Chief Financial Officer
5. Leader in Targeted Drug Development, Peter Hirth, Ph.D., Joins Trovagenes Scientific Advisory Board
6. American Botanical Council Publishes a History of Adulteration
7. Nucleic Acids Research Journal Publishes Sapphire Energy Peer-Reviewed Research Paper on a Chloroplast Genome From Green Algae
8. Nonprofit Consortium Publishes Review of Skullcap Adulteration
9. Receptos Co-Publishes Highest Resolution G-Protein Coupled Receptor Structure to Date in Science
10. Seaside publishes research supporting disease-modifying potential of STX209 for fragile X syndrome
11. R&D Systems Publishes 100,000 Product Detail Web Pages
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... ... on what they believe could be a new and helpful biomarker for malignant ... Click here to read it now. , Biomarkers are components in ...
(Date:6/27/2016)... June 27, 2016  Liquid Biotech ... funding of a Sponsored Research Agreement with The ... cells (CTCs) from cancer patients.  The funding will ... levels correlate with clinical outcomes in cancer patients ... will then be employed to support the design ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial ... Cary 5000 and the 6000i models are higher end machines that use the more ... the spectrophotometer’s light beam from the bottom of the cuvette holder. , FireflySci ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
Breaking Biology Technology:
(Date:6/20/2016)... June 20, 2016 Securus Technologies, a ... solutions for public safety, investigation, corrections and monitoring ... involved, it has secured the final acceptance by ... for Managed Access Systems (MAS) installed. Furthermore, Securus ... to be installed by October, 2016. MAS distinguishes ...
(Date:6/9/2016)... -- Paris Police Prefecture ... to ensure the safety of people and operations in several ... tournament Teleste, an international technology group specialised in ... that its video security solution will be utilised by ... safety across the country. The system roll-out is scheduled for ...
(Date:6/2/2016)... The Weather Company , an IBM Business (NYSE: IBM ... which consumers will be able to interact with IBM Watson ... or text and receive relevant information about the product or ... long sought an advertising solution that can create a one-to-one ... valuable; and can scale across millions of interactions and touchpoints. ...
Breaking Biology News(10 mins):